Screening studies typically are abbreviated versions of regulatory-compliant assays and require far less test compound. They allow us to predict results in subsequent regulatory standard GLP-compliant assays.
The following studies efficiently screen many compounds affordably with shorter turn-around times. Customization is available.
| Screening Services & Tests | Hazard Identification (in vitro) |
|---|---|
| Ames test | * |
| Gene mutation | * |
| Chromosomal aberration | * |
| Micronucleus | ** |
| Comet | * |
| Non-disjunction testing using FISH or antikinetochore | * |
| Cytotoxicity & phototoxicity | * |
The world’s demand for safe products is growing, and the demand for innovation in genetic toxicology and in vitro models is growing along with it. This is why we have expanded our genetic toxicology facilities by 30 percent, including new in vitro alternatives. Explore all of your genetic toxicology study options.
We’ve invested more than $700 million in scientific innovations to advance your nonclinical studies. With our expanded lab space, newest technologies and digitized back offices, the solutions we provide are more innovative than ever.
